Full Text
CV4 ASSESSING COST-EFFECTIVENESS BEFORE MARKETING- A CASE-STUDY OF RIMONABANT FOR REDUCTION OF CARDIOMETABOLIC RISK IN PATIENTS WITH DYSLIPIDEMIA IN THE UK

Abstract

Authors

JJ Caro D Getsios I Proskorovsky C Nicholls P McEwan

Back to Volume 9, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×